Journal:
:iranian journal of pharmaceutical research
0
omid gholami pharmacology department, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran
mahmood jeddi-tehrani monoclonal antibody research center, avicenna research institute, acecr, tehran, iran
mehrdad iranshahi biotechnology research center and school of pharmacy, mashhad university of medical sciences, mashhad, iran
amir hassan zarnani nanobiotechnology research center, avicenna research institute, acecr, tehran, iran
seyed ali ziai pharmacology department, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran
chronic lymphocytic leukaemia (cll) is the most common b-cell malignancy in the western world and exists as subtypes with very different clinical courses. myeloid cell leukemia 1 (mcl-1) is one member of bcl-2 family proteins that has been shown to be expressed in various tissues and malignant cells, including cll, where its expression is significantly associated with a failure to achieve compl...